Correlation Between Suzhou Novoprotein and Accelink Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Suzhou Novoprotein and Accelink Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Suzhou Novoprotein and Accelink Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Suzhou Novoprotein Scientific and Accelink Technologies Co, you can compare the effects of market volatilities on Suzhou Novoprotein and Accelink Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Suzhou Novoprotein with a short position of Accelink Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Suzhou Novoprotein and Accelink Technologies.

Diversification Opportunities for Suzhou Novoprotein and Accelink Technologies

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Suzhou and Accelink is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Suzhou Novoprotein Scientific and Accelink Technologies Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Accelink Technologies and Suzhou Novoprotein is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Suzhou Novoprotein Scientific are associated (or correlated) with Accelink Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Accelink Technologies has no effect on the direction of Suzhou Novoprotein i.e., Suzhou Novoprotein and Accelink Technologies go up and down completely randomly.

Pair Corralation between Suzhou Novoprotein and Accelink Technologies

Assuming the 90 days trading horizon Suzhou Novoprotein Scientific is expected to generate 0.83 times more return on investment than Accelink Technologies. However, Suzhou Novoprotein Scientific is 1.2 times less risky than Accelink Technologies. It trades about -0.09 of its potential returns per unit of risk. Accelink Technologies Co is currently generating about -0.28 per unit of risk. If you would invest  3,907  in Suzhou Novoprotein Scientific on September 12, 2024 and sell it today you would lose (182.00) from holding Suzhou Novoprotein Scientific or give up 4.66% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Suzhou Novoprotein Scientific  vs.  Accelink Technologies Co

 Performance 
       Timeline  
Suzhou Novoprotein 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.
Accelink Technologies 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Accelink Technologies Co are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Accelink Technologies sustained solid returns over the last few months and may actually be approaching a breakup point.

Suzhou Novoprotein and Accelink Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Suzhou Novoprotein and Accelink Technologies

The main advantage of trading using opposite Suzhou Novoprotein and Accelink Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Suzhou Novoprotein position performs unexpectedly, Accelink Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Accelink Technologies will offset losses from the drop in Accelink Technologies' long position.
The idea behind Suzhou Novoprotein Scientific and Accelink Technologies Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Commodity Directory
Find actively traded commodities issued by global exchanges